Yes, thank you.
On the last issue, we deal with the drug program managers and health ministries in all the provinces, and I think as long as they are paying for the drugs, there is virtually no chance they are ever going to cede authority back to some other agency as to which drugs they pay for.
I would comment again that the common drug review, as Mr. Williams said, is not a creation of the federal government; it was actually coming from the federal-provincial-territorial groups that have been meeting. In many ways, it's actually the desire of the provinces, in particular the smaller provinces, who simply don't have, or feel they don't have, adequate resources to review the cost-effectiveness and therapeutic value of all of these new medicines.